Hesio (Diosmin, Hesperidin)

Hesio is commonly employed to address conditions related to impaired venous return, capillary fragility, and associated discomfort.

• Chronic venous insufficiency, characterized by leg heaviness, swelling, skin changes, and ulceration.
• Symptomatic relief of hemorrhoidal disease, including bleeding, pain, prolapse, and itching.
• Management of varicose veins to reduce discomfort, edema, and prevent progression.
• Support of microvascular health in patients with capillary hyperpermeability and inflammation.
• Adjunctive therapy for peripheral circulatory disorders when combined with compression or lifestyle measures, and improve walking tolerance.
• Prevention of recurrence of minor bleeding episodes in patients with chronic hemorrhoidal disease.

• Both diosmin and hesperidin are flavonoid glycosides that act as vasoprotective agents. After oral absorption, they are metabolized to active aglycones that enhance venous tone by increasing smooth‑muscle contractility and reducing venous capacitance. The compounds also strengthen capillary walls through collagen synthesis, decrease endothelial permeability, and exert anti‑inflammatory effects by inhibiting prostaglandin and leukotriene pathways, thereby improving microcirculatory flow and overall vascular health.

Adverse reactions to Hesio are generally mild, but rare serious events have been reported.

Common

• Gastrointestinal discomfort such as nausea, abdominal pain, or dyspepsia.
• Headache or mild dizziness.
• Transient skin flushing or warmth.
• Mild insomnia or sleep disturbance.
• Temporary increase in blood pressure readings.
• Dry mouth or altered taste sensation.
• Mild fatigue or feeling of weakness.
• Transient visual disturbances such as blurred vision.

Serious

• Allergic reactions including rash, pruritus, or angio‑edema.
• Severe gastrointestinal bleeding or ulceration.
• Hepatic enzyme elevation or liver dysfunction.
• Thrombotic events such as deep vein thrombosis (rare).
• Renal impairment manifested by elevated creatinine.
• Severe hypotension leading to dizziness or syncope.
• Anaphylactic shock (extremely rare).
• Cardiac arrhythmias reported in isolated cases.

When considering Hesio, several precautionary measures should be observed to minimize risk and ensure appropriate use.

• Assess for known hypersensitivity to diosmin, hesperidin, or related flavonoids before initiating therapy.
• Use cautiously in patients with hepatic or renal impairment, adjusting duration as clinically indicated.
• Monitor blood pressure periodically, especially in individuals with a history of hypertension or hypotension.
• Avoid use during pregnancy or lactation unless the benefit outweighs potential risk, due to limited safety data.
• Consider potential interactions with anticoagulants or antiplatelet agents and evaluate bleeding risk.
• Discontinue if signs of severe allergic reaction or hepatic dysfunction appear.
• Consult a healthcare professional before combining with other vasoprotective supplements.

Hesio may affect the activity of certain medicines; awareness of these interactions helps maintain therapeutic safety.

Avoid

• Concomitant use with high‑dose anticoagulants (e.g., warfarin, apixaban) due to increased bleeding risk.
• Combination with potent antiplatelet agents (e.g., clopidogrel, aspirin) without medical supervision.

Use with caution

• Co‑administration with other flavonoid supplements may potentiate vasoprotective effects and cause additive side effects.
• Concurrent use of diuretics may enhance hypotensive effects; monitor blood pressure.
• Patients on hepatically metabolized drugs (e.g., statins, certain antihypertensives) should be observed for altered plasma levels.
• NSAIDs may increase gastrointestinal irritation when taken together; consider gastro‑protective measures.